Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-10 Purchase | 2023-03-10 09:17 am | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Sumitomo Pharma Co. Ltd. Sumitovant Biopharma Ltd. 10% Owner | 51,599,200 | $27 | $1,393,178,400 | 45,798,176 (Indirect) | View |
| 2023-01-18 Sale | 2023-01-20 4:36 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 1,272 | $26.89 | $34,204 | 354,303 (Direct) | View |
| 2023-01-18 Sale | 2023-01-20 4:34 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 2,008 | $26.89 | $53,995 | 169,538 (Direct) | View |
| 2023-01-18 Sale | 2023-01-20 4:34 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 8,037 | $26.89 | $216,115 | 417,599 (Direct) | View |
| 2023-01-18 Sale | 2023-01-20 4:31 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,109 | $26.89 | $29,821 | 246,684 (Direct) | View |
| 2023-01-04 Sale | 2023-01-05 5:21 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 2,251 | $26.9 | $60,552 | 247,793 (Direct) | View |
| 2023-01-04 Sale | 2023-01-05 5:20 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 2,779 | $26.9 | $74,755 | 355,575 (Direct) | View |
| 2022-12-16 Sale | 2022-12-20 8:07 pm | Myovant Sciences Ltd. | MYOV | Mehra Uneek Principal Financial Officer | 2,241 | $26.75 | $59,947 | 202,696 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:54 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 1,703 | $25.2 | $42,916 | 171,546 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:53 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 11,156 | $25.2 | $281,131 | 425,636 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:51 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 1,933 | $25.2 | $48,712 | 358,354 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:50 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,604 | $25.2 | $40,421 | 250,044 (Direct) | View |
| 2022-10-04 Sale | 2022-10-06 4:28 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 2,738 | $24.4 | $66,807 | 251,648 (Direct) | View |
| 2022-10-04 Sale | 2022-10-06 4:26 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 3,679 | $24.4 | $89,768 | 360,287 (Direct) | View |
| 2022-09-16 Sale | 2022-09-20 4:56 pm | Myovant Sciences Ltd. | MYOV | Mehra Uneek Principal Financial Officer | 9,243 | $18.86 | $174,323 | 204,937 (Direct) | View |
| 2022-08-15 Sale | 2022-08-16 5:01 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 31,214 | $18.23 | $569,031 | 363,966 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:38 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 1,935 | $12.87 | $24,903 | 270,400 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:37 pm | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 1,704 | $12.87 | $21,930 | 173,249 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:36 pm | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 11,164 | $12.87 | $143,681 | 436,792 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:35 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,606 | $12.87 | $20,669 | 254,386 (Direct) | View |
| 2022-07-06 Sale | 2022-07-08 4:09 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 2,755 | $13.4 | $36,917 | 255,992 (Direct) | View |
| 2022-07-06 Sale | 2022-07-08 4:08 pm | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 3,702 | $13.4 | $49,607 | 272,335 (Direct) | View |
| 2022-05-27 Sale | 2022-06-01 4:20 pm | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 1,382 | $10.07 | $13,917 | 258,747 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-10 Disposition | 2023-03-10 09:32 am | N/A 2031-11-04 | Myovant Sciences Ltd. | MYOV | Valente Nancy Director | 40,565 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:32 am | N/A 2028-09-19 | Myovant Sciences Ltd. | MYOV | POTTER MYRTLE S Director | 149,980 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:31 am | N/A 2031-04-14 | Myovant Sciences Ltd. | MYOV | Merendino Lauren Chief Commercial Officer | 396,541 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:31 am | N/A 2031-09-14 | Myovant Sciences Ltd. | MYOV | Mehra Uneek Principal Financial Officer | 478,999 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:30 am | N/A 2031-01-14 | Myovant Sciences Ltd. | MYOV | Marek David C Principal Executive Officer | 1,271,619 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:29 am | N/A 2027-07-16 | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 1,185,280 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:28 am | N/A 2030-02-23 | Myovant Sciences Ltd. | MYOV | Gulfo Adele M. Director | 91,372 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:28 am | N/A 2028-07-22 | Myovant Sciences Ltd. | MYOV | GUINAN MARK Director | 149,980 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:27 am | N/A 2026-11-14 | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 141,622 | $0 | 0 (Direct) | View |
| 2023-03-10 Disposition | 2023-03-10 09:24 am | N/A 2027-08-14 | Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer | 849,203 | $0 | 0 (Direct) | View |
| 2023-03-03 Other | 2023-03-06 06:15 am | 2023-03-03 2023-03-30 | Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Sumitomo Pharma Co. Ltd. Sumitovant Biopharma Ltd. 10% Owner | 4,243,006 | $0 | 50,041,182 (Indirect) | View |
| 2022-10-26 Option Award | 2022-10-28 4:45 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Curran Terrie Director | 9,859 | $0 | 9,859 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-28 4:41 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | GUINAN MARK Director | 9,859 | $0 | 9,859 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-28 4:38 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Gulfo Adele M. Director | 9,859 | $0 | 9,859 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-28 4:36 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | POTTER MYRTLE S Director | 9,859 | $0 | 9,859 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-28 4:34 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Valente Nancy Director | 9,859 | $0 | 9,859 (Direct) | View |
Ownership | 2022-10-21 5:15 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Nishinaka Shigeyuki Director | 0 | $0 | 0 (Direct) | View |
| 2022-08-12 Option Award | 2022-08-16 5:01 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. | 124,780 | $0 | 363,966 (Direct) | View |